American Bio Medica Short Interest Ratio and Short Volume

Short interest is the volume of American Bio Medica shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 11,900 shares of ABMC short. 0.00% of American Bio Medica's shares are currently sold short. View details.

American Bio Medica saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 11,900 shares, an increase of 11,800.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of American Bio Medica's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to American Bio Medica: Midatech Pharma PLC-ADR (0.00%), Generex Biotechnology Co. (0.00%), Spring Bank Pharmaceuticals Inc (0.59%), Acasti Pharma Inc (1.17%), AzurRx BioPharma Inc (0.69%), Novus Therapeutics Inc (0.00%), AEterna Zentaris Inc. (3.10%), Eyegate Pharmaceuticals Inc (0.61%), Intec Pharma Ltd (0.00%), and Guardion Health Sciences Inc (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.17 billion), Aon PLC ($3.57 billion), ViacomCBS Inc. ($3.01 billion), Clorox Co ($2.91 billion), Charles Schwab Co. ($2.80 billion), Mercadolibre Inc ($2.33 billion), Analog Devices, Inc. ($2.14 billion), Kroger Co ($1.99 billion), Moderna Inc ($1.96 billion), and Simon Property Group Inc ($1.80 billion). View all of the most shorted stocks.

Short selling ABMC is an investing strategy that aims to generate trading profit from American Bio Medica as its price is falling. American Bio Medica's stock is trading up $0.01 today. To short American Bio Medica stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that American Bio Medica will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for American Bio Medica occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABMC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABMC, twice per month. The most recent reporting period available is September, 15 2020.